Antagonist antibody to NPR1, REGN-NPR17544 (baloncibart), increases blood pressure and plasma volume
Hypotension and hypovolemia cause morbidity across many clinical disorders, yet pharmacologic options are limited. REGN-NPR1 7544 (REGN7544/baloncibart), a first-in-class monoclonal antibody, allosterically antagonizes natriuretic peptide receptor 1 (NPR1), a membrane guanylyl cyclase activated by atrial natriuretic peptide (ANP) and brain natriuretic peptide to promote vasorelaxation and natriuresis. REGN-NPR1 7544 bound human and cynomolgus monkey NPR1 with nanomolar affinity, increased systolic blood pressure (SBP) in NPR1 Hu/Hu mice by 10–15 mmHg for up to 28 days, corrected severe hypotension in ANP-overexpressing mice, and inhibited ANP-induced mesenteric vessel relaxation. In monkeys, SBP increased by 15–20 mmHg, with biomarkers consistent with plasma volume expansion. In a randomized, placebo-controlled, phase 1 single-ascending-dose study in healthy adults (N = 80), doses ≥ 100 mg were generally well-tolerated, producing sustained 5–10 mmHg SBP increases and biomarker signals consistent with volume expansion. These data implicate tonic NPR1 signaling in human blood pressure and volume regulation, supporting REGN-NPR1 7544 as a candidate for hypotension and hypovolemia.
Authors
- Ashique Rafique (ORCID: https://orcid.org/0000-0003-4078-7242)
- Pamela Krueger (ORCID: https://orcid.org/0000-0002-6166-7189)
- Benjamin A. Olenchock (ORCID: https://orcid.org/0000-0002-8956-5117)
- Lori G. Morton (ORCID: https://orcid.org/0000-0002-5214-5784)
- Annabel Romero Hernandez (ORCID: https://orcid.org/0000-0002-5119-2319)
- Andre Jo-Hao Ho
- Justin Torello
- Akshay Shekhar (ORCID: https://orcid.org/0000-0002-9168-9987)
- Mazhar Thakur
- Sai Kiran Sharma (ORCID: https://orcid.org/0000-0002-8199-7601)
- Dipti K. Pawaskar
- Elena S. Garnova (ORCID: https://orcid.org/0000-0002-1678-6867)
- Hana A. Itani (ORCID: https://orcid.org/0000-0001-9921-5885)
- Hao Pan (ORCID: https://orcid.org/0009-0007-8325-7141)
- Kishor B. Devalaraja-Narashimha (ORCID: https://orcid.org/0000-0002-7583-3520)
- Raji Swamy
- Jee Kim
- Gary A. Herman (ORCID: https://orcid.org/0000-0003-4433-6529)
- George D. Yancopoulos
- Ethan P. Marin (ORCID: https://orcid.org/0000-0001-6956-7978)
- Katie Tuckwell (ORCID: https://orcid.org/0000-0002-6918-822X)
- Mao Wang (ORCID: https://orcid.org/0000-0001-7545-4048)
- Andrew J. Murphy (ORCID: https://orcid.org/0000-0003-4152-4081)
- Chris Wynne
- Emily Redington
- Tammy Huang
- Ximei Jin
- Xia Mao
- Mohsin Ahmed
- Meng Xu
- Matthew Franklin
- Michael Dunn
- Xiping Cheng
- William Olson
- Kevin Guley
- Dongqin Zhang
Institutions
- Regeneron (United States) (US)
- New Zealand Clinical Research (NZ)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-10779601/v1
- Primary Topic
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Type
- preprint